Linus Pauling Institute

Jump DB, Depner CM, Tripathy S, Lytle KA.  2016.  Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.. Proc Nutr Soc. 75(1):1-9.

Lytle KA, Depner CM, Wong CP, Jump DB.  2015.  Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.. J Lipid Res. 56(10):1936-46.

Jump DB, Depner CM, Tripathy S, Lytle KA.  2015.  Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.. Adv Nutr. 6(6):694-702.

Jump DB, Tripathy S, Depner CM.  2013.  Fatty acid-regulated transcription factors in the liver.. Annu Rev Nutr. 33:249-69.

Depner CM, Traber MG, Bobe G, Kensicki E, Bohren KM, Milne G, Jump DB.  2013.  A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.. PLoS One. 8(12):e83756.

Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB.  2012.  Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.. J Nutr. 142(8):1495-503.

Jump DB, Depner CM, Tripathy S.  2012.  Omega-3 fatty acid supplementation and cardiovascular disease.. J Lipid Res. 53(12):2525-45.